Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05LDK
|
|||
| Former ID |
DIB006510
|
|||
| Drug Name |
IPX203
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 2 | [1] | |
| Company |
Impax pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02271503) A Study to Assess the PK and Pharmacodynamics (PD) of IPX203 in Patients With Advanced Parkinsons Disease. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.